[ORGANIZATION]

HUTCHMED

Featured in 2 tracked stories · first seen about 1 month ago

Situations

[ACTIVE] [BUSINESS] [US] [EU] [CN]

AstraZeneca regulatory and portfolio developments

3 clusters · 5 sources · last updated 2 days ago

Latest: AstraZeneca and Johnson & Johnson advance new cancer treatments

AstraZeneca has achieved several regulatory milestones regarding its oncology and rare disease pipelines. In Europe, the company received approval for Enhertu in combination with pertuzumab for first-line treatment of HE

[QUIET] [HEALTH] [CN] [IT]

Osimertinib efficacy and evolving NSCLC treatment trends

4 clusters · 18 sources · last updated 11 days ago

Latest: Italy advances cancer prevention and oncology treatments

Updated data from the Phase III ADAURA study, presented at the World Conference on Lung Cancer in Seoul, indicates that osimertinib provides sustained and clinically significant overall survival benefits for patients wit